Cockayne syndrome mice reflect human kidney disease and are defective in de novo NAD biosynthesis
Authors:
- Thomas KulikowiczTKThomas Kulikowicz
Preprint
- 10 October 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Cockayne Syndrome (CS) is a premature aging disorder caused by mutations in the CSA and CSB genes involved in DNA metabolism and other cellular processes. CS patients display many features including premature aging, neurodegeneration, and kidney abnormalities. Nicotinamide dinucleotide (NAD+) deprivation has been oberserved in CS patient-derived cells. NAD+ has essential roles in regulating cellular health, stress responses, and renal homeostasis. While kidney dysfunction is a common featurein CS patients, its molecular pathogenesis is not understood. Here, we report that severe kidney pathology is present in CS A and B mice. We find that the NAD+ biosynthetic pathways are impaired in kidneys from these mice. Using human renal tubular epithelial cells, we show that CSA/B downregulation causes persistent activation of the ATF3 transcription factor on the quinolinate phosphoribosyl transferase gene locus, a rate-limiting enzyme in de novo NAD+ biosynthesis in the kidney, causing impaired transcription and deficient NAD+ homeostasis.Keywords
All Related Versions
This publication has 61 references indexed in Scilit:
- Renal disease in Cockayne syndromeEuropean Journal of Medical Genetics, 2020
- Quantitative Analysis of NAD Synthesis-Breakdown FluxesCell Metabolism, 2018
- Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General PopulationKidney International Reports, 2017
- Activation of SIRT3 by the NAD+ Precursor Nicotinamide Riboside Protects from Noise-Induced Hearing LossCell Metabolism, 2014
- A High-Fat Diet and NAD + Activate Sirt1 to Rescue Premature Aging in Cockayne SyndromeCell Metabolism, 2014
- NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial DiseaseCell Metabolism, 2014
- Defective Mitophagy in XPA via PARP-1 Hyperactivation and NAD+/SIRT1 ReductionCell, 2014
- The Molecular Basis of CRL4DDB2/CSA Ubiquitin Ligase Architecture, Targeting, and ActivationCell, 2011
- Cockayne syndrome: Review of 140 casesAmerican Journal of Medical Genetics, 1992
- Renal lesions in Cockayne syndromePediatric Nephrology, 1988